Teladoc Health, Inc.
Financials
Valuation Metrics
Teladoc Health, Inc.'s Market Cap is $1.14B. At end of 2025 it was $1.23B. Ranked #2400 of 3,121 in US market (top 77%), #1427 of 1,658 on NYSE (top 86%), #150 of 205 in Health Care Equipment & Services (top 73%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.14B | US#2,400/3,121 Sec#150/205 |
| Revenue | $2.49B | US#1,315/3,121 Sec#82/205 |
| Net Income | $-177M | US—/3,121 Sec—/205 |
| Total Assets | $2.76B | US#1,875/3,121 Sec#91/205 |
| Net Assets | $1.31B | US#1,582/3,121 Sec#85/205 |
| Employees | 5,124 | US#1,221/3,121 Sec#88/205 |
| Value | ||
| P/B | 0.87x | US#274/3,121 Sec#17/205 |
| P/S | 0.46x | US#286/3,121 Sec#27/205 |
| FCF Yield | 19.75% | US#164/3,121 Sec#6/205 |
| Profitability | ||
| ROE | -13.54% | US#2,418/3,121 Sec#140/205 |
| ROA | -6.43% | US#2,580/3,121 Sec#145/205 |
| Op. Margin | -6.98% | US#2,512/3,121 Sec#150/205 |
| Revenue Growth | -2.08% | US#2,376/3,121 Sec#173/205 |
| Financial Health | ||
| Debt Ratio | 110.56% | US#1,201/3,121 Sec#112/205 |
| Total Debt | $1.04B | US#1,525/3,121 Sec#81/205 |
| FCF | $225M | US#1,324/3,121 Sec#76/205 |
| Cash | $774M | US#812/3,121 Sec#41/205 |
| Current Ratio | 0.83x | US#2,474/3,121 Sec#198/205 |
| Performance | ||
| 1Y Return | -23.73% | US#2,408/3,121 Sec#162/205 |
| 1M Return | -5.41% | US#1,354/3,121 Sec#117/205 |
| From 52W High | -36.30% | US#2,359/3,121 Sec#156/205 |
| 1Y MDD | -52.75% | US#2,564/3,121 Sec#154/205 |
| Trading | ||
| Volume | 2,601,462 shares | US#795/3,121 Sec#44/205 |
| Trading Value | $16M | US#2,164/3,121 Sec#144/205 |
| Per Share | ||
| EPS | $-0.98 | US—/3,121 Sec—/205 |
| BPS | $7.26 | US#2,065/3,121 Sec#121/205 |
Company Info
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.